Candy Mavis Rivas

Title: Innovations of Candy Mavis Rivas

Introduction

Candy Mavis Rivas is an accomplished inventor based in Tucson, AZ. She has made significant contributions to the field of biotechnology, particularly in the detection of COVID-19 variants. With a total of 4 patents to her name, Rivas is recognized for her innovative approaches to addressing public health challenges.

Latest Patents

One of her latest patents is a combinatorial microarray assay for clade variant detection. This method allows for the detection of clade variants in the COVID-19 virus from human and environmental samples. The process involves obtaining total RNA from samples, which is then used as a template in a combined reverse transcription and amplification reaction. This results in fluorescent COVID-19 virus amplicons that are hybridized on a microarray with nucleic acid probes. These probes have sequences that can discriminate among various clade variants. The microarray is then imaged to detect the clade variant, and each variant is distinguished by generating a unique intensity distribution profile from the image.

Career Highlights

Rivas is currently employed at Pathogendx, Inc., where she continues to develop innovative solutions in the field of diagnostics. Her work has been instrumental in advancing methods for detecting viral variants, which is crucial for effective public health responses.

Collaborations

Some of her notable coworkers include Benjamin Alan Katchman and Michael E Hogan. Their collaborative efforts contribute to the success of the projects at Pathogendx, Inc.

Conclusion

Candy Mavis Rivas exemplifies the spirit of innovation in biotechnology. Her work in developing methods for detecting COVID-19 variants showcases her commitment to improving public health through scientific advancements.